As cells die, they shed DNA fragments into the blood. By analyzing these DNA fragments with a blood test, we can identify what organ the DNA comes from and whether that organ is healthy or diseased before symptoms appear, imaging is viable, or a biopsy is possible. But until now, emerging blood tests have not met clinical expectations because their suboptimal AI models are designed and trained on opaque, chaotic blood data.

Curve is creating a Whole-Body Intelligence platform anchored in verified biological truth. This starts with our Whole-Body Atlas — the largest collection of manually-curated tissue samples characterized by organ and disease state. Our atlas returns us to clarity by connecting the methylation pattern of each DNA fragment in the blood with its source organ to analyze the organ’s health. We bring this Whole-Body Intelligence to chronic disease patients through our Whole-Body Blood Tests, which deliver optimal accuracy and outcomes.